CRVO
CervoMed Inc.
$3.41
-0.01 (-0.29%)
At close · Jul 8
Market Cap
$34.63M
Shares
9,258,719
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.41
Open$3.33
Day$3.33–3.59
52W$2.13–13.13
Avg vol 30d11.3M
Short int344K · 3.7% float · 1.0d
Short vol72%
Last earningsJun 15, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.8 · calm
Equity put/call 0.57
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−40%
below
Price vs 50-day avg
+1%
above
RSI (14)
50
neutral
MACD trend
Positive
52-week position
12%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+17%
trailing
6-month return
−55%
trailing
YTD return
−57%
this year
Relative strength
−62%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $6 — 200d above 50d
Institutional flow
Accumulating
1 of 36 funds reported for Jun 30 · net +36.6K sh shares
Insider flow
Accumulating
Net +$3.0M over 90 days · 0% sells
Short interest
Rising
3.71% of float · ▲ +30.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
36 holders — mid 3-yr range
Squeeze score
55
elevated · 0–100
Fundamentals
Revenue growth
−59%
Y/Y
Gross margin
2%
expanding
EPS growth
+5%
Y/Y
Free cash flow
$-23.9M
Balance sheet
$6.6M
net cash
Quant / Vol
risk profile
Volatility
115%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
16.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Nov 4, 2026
Est · unconfirmed
· in 17 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−40%
Bearish
Price vs 50-day avg
+1%
Bullish
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
12%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $3 › 200d $6 — 200d above 50d
Institutional flow
Accumulating
1 of 36 funds reported for Jun 30 · net +36.6K sh shares
Insider flow
Accumulating
Net +$3.0M over 90 days · 0% sells
Short interest
Rising
3.71% of float · ▲ +30.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
36 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $2
Now $3 · 12%
52-wk high $13
vs 200-day avg -40%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRVO
this stock
CervoMed Inc.
|
$34.63M | -56.8% | -58.9% | — | 3.7% |
|
ONC
BeOne Medicines Ltd.
|
$437.67B | -0.6% | +22179.2% | 890.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.01B | +9.9% | +46.2% | 29.5 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.03B | -14.0% | +20.8% | 16.3 | 3.2% |
|
ARGX
Argenx SE
|
$56.84B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRVO | +10.0% | +17.2% | -54.8% | +10.0% | -56.8% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | +10.2% | +16.3% | -62.2% | +10.2% | -66.2% |